News

Trimel Reports Fourth Quarter and Full Year 2013 Financial Results
March 05, 2014

Toronto, Canada, March 5, 2014 – Trimel Pharmaceuticals Corporation (TSX: TRL) today provided an overview of its corporate accomplishments and r...

Read the rest of this article...

Trimel to Report Financial Results for 2013 and Host Conference Call to Update Investors
February 27, 2014

Toronto, Canada, February 27, 2014 – Trimel Pharmaceuticals Corporation (TSX: TRL) will report its financial results for the 3 month and 12 mont...

Read the rest of this article...

Trimel Announces Closing of $10.5 Million Private Placement of Common Shares
February 21, 2014

Toronto, Canada, February 21, 2014 – Trimel Pharmaceuticals Corporation (TSX: TRL) announced today that the previously disclosed private placeme...

Read the rest of this article...

Trimel Announces $10.5 Million Private Placement of Common Shares
February 19, 2014

Toronto, Canada, February 19, 2014 – Trimel Pharmaceuticals Corporation (TSX: TRL) announced today that it has entered into subscription agreeme...

Read the rest of this article...

Trimel Announces Appointment of New Vice President, Scientific Affairs
January 23, 2014

Toronto, Canada, January 23, 2014 – Trimel Pharmaceuticals Corporation (TSX: TRL) is pleased to announce the appointment of Dr. Nathan Bryson to...

Read the rest of this article...

Trimel Provides Update Regarding CompleoTRT(TM) FDA Review
January 17, 2014

Toronto, Canada, January 17, 2014 – Trimel Pharmaceuticals Corporation (TSX: TRL) today announced that the United States Food and Drug Administr...

Read the rest of this article...

Trimel Announces Appointment of Tom Rossi to its Board of Directors
January 16, 2014

Toronto, Canada, January 16, 2014 – Trimel Pharmaceuticals Corporation (TSX: TRL) today announced the appointment of Mr. Tom Rossi, the company&...

Read the rest of this article...

Trimel Completes Enrollment of Tefina(TM) Ambulatory Study
January 14, 2014

Toronto, Canada, January 14, 2014 – Trimel Pharmaceuticals Corporation (TSX: TRL) is pleased to announce that it has completed enrollment of its...

Read the rest of this article...

Trimel Announces Retirement of Chair and Appointment of New Chair
January 10, 2014

Toronto, Canada, January 10, 2014 – Trimel Pharmaceuticals Corporation (TSX: TRL) today announced the retirement of Mr. Bruce Brydon as Chair of...

Read the rest of this article...

Trimel Announces Resolution of Arbitration Matters With M&P Patent AG
December 22, 2013

TORONTO, ONTARIO--(Dec. 22, 2013) - Trimel Pharmaceuticals Corporation (TSX:TRL) is pleased to announce that its subsidiary, Trimel BioPharma SRL...

Read the rest of this article...

Trimel Announces Update on CompleoTRT(TM)
December 19, 2013

Trimel Announces Update on CompleoTRT(TM) TORONTO, ONTARIO--(Dec. 19, 2013) - Trimel Pharmaceuticals Corporation (TSX:TRL) today announced an upd...

Read the rest of this article...

Trimel Pharmaceuticals Corporation Announces Appointment of New Director
November 27, 2013

TORONTO, ONTARIO--(Marketwired - Nov. 27, 2013) - Trimel Pharmaceuticals Corporation (TSX:TRL) today announced the appointment of Mr. Matthew Pfeffer ...

Read the rest of this article...

Trimel Pharmaceuticals Corporation Provides Third Quarter Financial Results and Update
November 03, 2013

  - Ending Cash Balance at September 30, 2013 Totalled $24 Million - Third Quarter 2013 Average Monthly Burn Rate Totalled $2.1 Million - Te...

Read the rest of this article...

Trimel Announces Update Regarding CompleoTRT(TM) FDA Review
October 24, 2013

TORONTO, ONTARIO--(Marketwired - Oct. 24, 2013) - Trimel Pharmaceuticals Corporation (TSX:TRL) today announced that the Company has received an inform...

Read the rest of this article...

Trimel Pharmaceuticals Corporation Announces Appointment of New Director
September 09, 2013

TORONTO, ONTARIO--(Marketwired - Sept. 9, 2013) - Trimel Pharmaceuticals Corporation (TSX:TRL) is pleased to announce the appointment of Mr. Ian ...

Read the rest of this article...

Page 1 of 7First   Previous   [1]  2  3  4  5  6  7  Next   Last   
© 2014 by Trimel Pharmaceuticals Corporation